As healthcare providers (HCPs) are increasingly relying on evidence-based data and clinical guidelines, life science organizations must shift their focus to enabling HCPs in the effective adoption of these medicines. Medical affairs teams and medical science liaisons play a critical role in the success of therapies reaching clinical care.
In this video, we discuss how medical affairs teams and MSLs can drive successful adoption of therapies by closing care gaps and increasing scientific share of voice.
Speakers:
Stacey Rivkin
Group Vice President of Strategic Solutions, H1
Luca Dezzani
Vice President Medical Affairs Solid Tumor, JOHNSON & JOHNSON
31 май 2023
